Company Receives TSX Approval for Renewal of Normal Course Issuer Bid
DENVER, Sept. 29, 2025 /CNW/ - Ovintiv Inc. (NYSE:OVV), (TSX:OVV.TO) today announced it has received regulatory approvals for the renewal of its share buy-back program. This action is consistent with Ovintiv's capital allocation framework, which returns at least 50 percent of post base dividend Non-GAAP Free Cash Flow to shareholders.
Read more at newswire.caThis article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.